Underlying EBITDA is already $97M for FY18, with the increased in revenue of say 5-8% for FY19, and reduction of operating costs, the EBITDA can only go higher. I am anticipating anywhere between 5-10% increase in EBITDA for FY19.
- Forums
- ASX - By Stock
- Ann: FY18 Full Year Results - Investor Presentation
Underlying EBITDA is already $97M for FY18, with the increased...
-
-
- There are more pages in this discussion • 31 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add GXL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online